INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
1.490
-0.100 (-6.29%)
At close: Jun 5, 2025, 4:00 PM
1.490
0.00 (0.00%)
After-hours: Jun 5, 2025, 4:58 PM EDT
INVO Fertility Employees
As of December 31, 2024, INVO Fertility had 37 total employees, including 33 full-time and 4 part-time employees.
Employees
37
Change
n/a
Growth
n/a
Revenue / Employee
$178,186
Profits / Employee
-$679,826
Market Cap
3.20M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
IVF News
- 9 days ago - INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 - GlobeNewsWire
- 16 days ago - INVO Fertility Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA - GlobeNewsWire
- 6 weeks ago - INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF” - GlobeNewsWire
- 7 weeks ago - NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.” - GlobeNewsWire
- 3 months ago - NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 - GlobeNewsWire
- 3 months ago - NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment - GlobeNewsWire
- 3 months ago - NAYA Biosciences Announces Nomination of New Board Members - GlobeNewsWire